Rhythm Pharmaceuticals
OrganizationHeard in 2 episodes across 2 shows since Nov 2026
Rhythm Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for rare genetic diseases of obesity and related metabolic disorders.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
| Nov 2026 | 2 |
Email alert
Email me when Rhythm Pharmaceuticals comes up on a podcast
One email a week at most, with the new episodes that mention Rhythm Pharmaceuticals. Free, no account needed, unsubscribe in one click.
What experts have said about Rhythm Pharmaceuticals
5 statements · 5 positive
Rhythm Pharmaceuticals treats a rare genetic form of obesity.
“they treat a very rare form, a genetic form of obesity”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 22:01
Rhythm Pharmaceuticals’ drug received approval for an additional indication.
“The drug just got an additional indication approved”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 22:35
Rhythm Pharmaceuticals has strong revenue growth and fund sponsorship.
“Good revenue growth, good fund sponsorship.”
Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In FocusListen at 24:16
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring Rhythm Pharmaceuticals, newest first